Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients

Journal of Internal Medicine

Volumn 256, Issue 1, 2004, Pages 22-29

  Mule G ^a,b   Cottone, S ^a   Vadala A ^a   Volpe, V ^a   Mezzatesta, G ^a   Mongiovi R ^a   Piazza, G ^a   Nardi, E ^a   Andronico, G ^a   Cerasola, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Aortic stiffness; Arterial hypertension; Cardiovascular risk; Microalbuminuria; Pulse wave velocity

Indexed keywords

ALBUMIN;

ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL INJURY; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; COMPUTER AIDED DESIGN; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; EXCRETION; FEMALE; FEMORAL ARTERY; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; OUTPATIENT; PRIORITY JOURNAL; PULSE WAVE; REGRESSION ANALYSIS; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINURIA; AORTA; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING, AMBULATORY; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; ELASTICITY; FEMALE; FEMORAL ARTERY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULSE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 3042636431     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01338.x     Document Type: Article

References (41)

1. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003; 254: 45-66.
2. Cerasola G, Cottone S, D'Ignoto G et al. Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989; 7 (Suppl. 6): S332-3.
3. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14: 223-8.
4. Cerasola G, Cottone S, Mulè G et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996; 14: 915-20.
5. Bigazzi R, Blanchi S, Nenci R et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9: 827-33.
6. Mykkänen L, Zaccaro DJ, O'Leary DH et al. Microalbuminuria and carotid artery intima-media thickness in non-diabetic and NIDDM subjects. Stroke 1997; 28: 1710-6.
7. Andronico G, Ferrara L, Mangano M, Mulè G, Cerasola G. Insulin, sodium-lithium counter-transport, and microalbuminuria in hypertensive patients. Hypertension 1998; 31: 110-3.
8. Rodicio JL, Campo C, Ruilope LM. Microalbuminuria in essential hypertension. Kidney Int 1998; 54 (Suppl. 68): S51-4.
9. Tuttle KR, Puhlman ME, Cooney SK, Short R. Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. Am J Kidney Dis 1999; 34: 918-25.
10. Wachtell K, Palmieri V, Olsen MH et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143: 319-26.
11. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1998; 2: 530-3.
12. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300: 297-300.
13. Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion - a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770-8.
14. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects. Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-24.
15. Campese VM, Bianchi S, Bigazzi R. Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension? Curr Opin Nephrol Hypertens 2000; 9: 143-7.
16. Jensen JS, Feldt-Rasmussen B, Strandgaard S et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.
17. Gerstein HC, Mann JF, Yi Q et al. for HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-6.
18. Hillege HL, Fidler V, Diercks GFH et al. for the Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-2.
19. Asmar R. Arterial Stiffness and Pulse Wave Velocity. Clinical Applications. Paris: Elsevier, 1999; 25-134.
20. Blacher J, Safar M, Guerin A et al. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63: 1852-60.
21. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41.
22. Cruickshank K, Riste L, Anderson SG et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function? Circulation 2002; 106: 2085-90.
23. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004; 43: 163-8.
24. Palmieri V, Bella JN, Roman MJ et al. Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study. J Hypertens 2003; 21: 781-7.
25. Takegoshi T, Hirai J, Shimada T et al. The correlation between pulse wave velocity and diabetic angiopathy. Nippon Ronen Igakkai Zasshi 1991; 28: 664-7.
26. d'Esteve-Bonetti L, Amar J, Hanaire-Broutin H et al. Microalbuminuria, pulse wave velocity and common carotid artery intima-media thickness in type 2 diabetes. Arch Mal Coeur Vaiss 2001; 94: 795-8.
27. Tobbli JE, Bellido CA, Iavicoli OR et al. Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril. Medicina (B Aires) 2002; 62: 544-50.
28. Tsioufis C, Lambrou S, Stefanadis C et al. Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension. Am J Cardiol 2000; 86: 797-801.
29. Tsioufis C, Tzioumis C, Marinakis N et al. Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension. Nephron Clin Pract 2003; 93: 106-11.
30. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
31. O'Brien E, Waeber B, Parati G et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322: 531-6.
32. Asmar R, Benetos A, Topouchian J et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-90.
33. Redon J, Williams B. Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens 2002; 20: 353-5.
34. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K et al. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32: 219-26.
35. Mogensen CE. Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med 1994; 235: 297-316.
36. Cottone S, Vadalà A, Mangano MT et al. Endothelium-derived factors in microalbuminuric and nonmicroalbuminuric essential hypertensives. Am J Hypertens 2000; 13: 172-6.
37. Pedrinelli R, Giampietro O, Cammassi F et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-8.
38. Kinlay S, Creager MA, Fukumoto M et al. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001; 38: 1049-53.
39. Wilkinson IB, Qasem A, McEniery CM et al. Nitric oxide regulates local arterial distensibility in vivo, Circulation 2002; 105: 213-7.
40. Amar J, Ruidavets B, Chamontin B et al. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19: 381-7.
41. Lehmann ED, Hopkins KD, Rawesh A et al. Relation between number of cardiovascular risk factors/events and noninvasive Doppler ultrasound assessments of aortic compliance. Hypertension 1998; 32: 565-9.